243
Views
18
CrossRef citations to date
0
Altmetric
Pharmacotherapy: Quetiapine

Quetiapine in the Treatment of Sleep Disturbances Associated with Addictive Conditions: A Retrospective Study

, &
Pages 2169-2171 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kaisa E. Luoto, Antti Koivukangas, Antero Lassila & Olli Kampman. (2016) Outcome of patients with dual diagnosis in secondary psychiatric care. Nordic Journal of Psychiatry 70:6, pages 470-476.
Read now

Articles from other publishers (17)

Ulises Jiménez-Correa, Rafael Santana-Miranda, Andrés Barrera-Medina, Juan M. Martínez-Núñez, Hernán A. Marín-Agudelo, Adrián Poblano, Carlos H. Schenck & Irma Hernández-Berber. (2020) Parasomnias in patients with addictions—a systematic review. CNS Spectrums 27:1, pages 58-65.
Crossref
Ki Yong Lee, Seung-Ho Ryu, Jee Hyun Ha, Hong Jun Jeon & Doo-Heum Park. (2021) Prescription Dose Analysis of Quetiapine in the Elderly and Insomnia. Chronobiology in Medicine 3:4, pages 149-156.
Crossref
Kamila Czora-Poczwardowska, Radosław Kujawski, Julia Słyńko-Krzyżostaniak, Przemysław Ł. Mikołajczak & Michał Szulc. (2021) Orexin receptor blockers: A tool for lowering alcohol intake and alcohol addictive behavior in the light of preclinical studies. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 959-969.
Crossref
Maaike van Veen & Roelof Risselada. 2021. Slaapstoornissen in de psychiatrie. Slaapstoornissen in de psychiatrie 331 361 .
Víctor-Hugo González-Cárdenas, Evelyn Constantin, Marta Somaini, Anna Radzioch & Pablo M. Ingelmo. (2019) Pharmacologic Treatment of Insomnia in Children and Adolescents with Chronic Pain Conditions. Current Anesthesiology Reports 9:2, pages 85-91.
Crossref
Fabrizio Schifano, Stefania Chiappini, John Corkery & Amira Guirguis. (2018) Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. Brain Sciences 8:4, pages 73.
Crossref
Tobias Atkin, Stefano Comai & Gabriella Gobbi. (2018) Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacological Reviews 70:2, pages 197-245.
Crossref
Stefania ChiappiniFabrizio Schifano. (2018) Is There a Potential of Misuse for Quetiapine?. Journal of Clinical Psychopharmacology 38:1, pages 72-79.
Crossref
Anna K Morin. (2014) Off-label use of atypical antipsychotic agents for treatment of insomnia. Mental Health Clinician 4:2, pages 65-72.
Crossref
Sarah L. AndersonJoseph P. Vande Griend. (2014) Quetiapine for insomnia: A review of the literature. American Journal of Health-System Pharmacy 71:5, pages 394-402.
Crossref
Lara Grau-López, Carlos Roncero, Constanza Daigre, Laia Miquel, Carmen Barral, Begoña Gonzalvo, Francisco Collazos & Miquel Casas. (2014) Observational Study on Medications Prescribed to Dual-Diagnosis Outpatients. Journal of Addiction Medicine 8:2, pages 84-89.
Crossref
Siobhan Emma Reddel, Raimondo Bruno, Lucy Burns, Amy Kirwan, Kamalini Lokuge & Paul Dietze. (2014) Prevalence and associations of quetiapine fumarate misuse among an Australian national city sample of people who regularly inject drugs. Addiction 109:2, pages 295-302.
Crossref
Chintan Shah, Taral R. Sharma & Anita Kablinger. (2014) Controversies in the use of second generation antipsychotics as sleep agent. Pharmacological Research 79, pages 1-8.
Crossref
I.S. Hairston, N.Z. Akbar & D.A. Conroy. 2013. Encyclopedia of Sleep. Encyclopedia of Sleep 229 235 .
James R. Shoblock, Natalie Welty, Leah Aluisio, Ian Fraser, S. Timothy Motley, Kirsten Morton, James Palmer, Pascal Bonaventure, Nicholas I. Carruthers, Timothy W. Lovenberg, Jamin Boggs & Ruggero Galici. (2010) Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology 215:1, pages 191-203.
Crossref
Christian R. Dolder & Jonathan McKinsey. (2010) Quetiapine for Sleep in Patients with Dementia. The Consultant Pharmacist 25:10, pages 676-679.
Crossref
Simon Zhornitsky, Stéphane Potvin, Emmanuel Stip & Pierre-Paul Rompré. (2010) Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine. European Neuropsychopharmacology 20:10, pages 695-703.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.